Design and Immunological Evaluation of a Hybrid Peptide as a Potent TLR2 Agonist by Structure-Based Virtual Screening
Immunity is a flexible defensive response that’s concerned in defending in opposition to illness by figuring out and destroying self and non-self dangerous substances. As a state of non permanent or everlasting immune dysfunction, immunosuppression could make an organism extra inclined to an infection, organ harm, and most cancers attributable to harm to the immune system. It has taken a very long time to develop new immunomodulatory brokers to forestall and deal with immunosuppressive ailments.
In recent times, Toll-like receptor 2 (TLR2) agonists have been reported to have profound results on the immune system, and they’re thought to be potent immunomodulatory candidates. TP5 and LL-37, the potent immunomodulatory brokers, have been reported to provide a sturdy innate immune response by binding to TLR2. Nevertheless, their growth has been weakened by a number of considerations, reminiscent of potential cytotoxicity, weak physiological stability and poor immunomodulatory exercise.
To beat these challenges, hybridization has been proposed. Due to this fact, six hybrid peptides (LTPa, LTPb, LTPc, TPLa, TPLb, and TPLc) had been designed by combining the full-length TP5 with a attribute fragment of LL-37 that included LL-37 (13-36), LL-37 (17-29), and LL-37 (13-31). LTPa, probably the most potent TLR2 agonist, was merely and successfully screened by molecular docking and in vitro experiments.
Moreover, the immunomodulatory results of LTPa had been confirmed by a CTX-immunosuppressed murine mannequin, which demonstrated that LTPa efficiently inhibit immunosuppression, elevated immune organ indices, enhanced DC maturation, regulated T lymphocyte subsets, and elevated cytokine and Ig contents. Our examine additionally revealed that the immunomodulatory results of LTPa are related to binding to TLR2, forming TLR2 clusters, and activating the NF-κB signaling pathway.
Immunostimulatory TLR7 agonist-nanoparticles along with checkpoint blockade for efficient most cancers immunotherapy
Mono- or dual-checkpoint inhibitors for immunotherapy have modified the paradigm of most cancers care; nevertheless, solely a minority of sufferers responds to such therapy. Combining small molecule immuno-stimulators can enhance therapy efficacy, however they’re restricted by poor pharmacokinetics. On this examine, TLR7 agonists conjugated onto silica nanoparticles confirmed prolonged drug localization after intratumoral injection. The nanoparticle-based TLR7 agonist elevated immune stimulation by activating the TLR7 signaling pathway.
When treating CT26 colon most cancers, nanoparticle conjugated TLR7 agonists elevated T cell infiltration into the tumors by > 4× and upregulated expression of the interferon γ gene in comparison with its unconjugated counterpart by ~2×. Toxicity assays established that the conjugated TLR7 agonist is a protected agent on the efficient dose.
When mixed with checkpoint inhibitors that concentrate on programmed cell demise protein 1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), a 10-100× enhance in immune cell migration was noticed; moreover, 100 mm3 tumors had been handled and a 60% remission price was noticed together with remission at contralateral non-injected tumors. The info present that nanoparticle primarily based TLR7 agonists are protected and might potentiate the effectiveness of checkpoint inhibitors in immunotherapy resistant tumor fashions and promote a long-term particular reminiscence immune operate.
Detrimental Impression of Sigma-1 Receptor Agonist Remedy on Tissue Integrity and Motor Perform Following Spinal Wire Damage
In traumatic spinal wire harm, the preliminary trauma is adopted by a cascade of impairments, together with excitotoxicity and calcium overload, which finally induces secondary damages. The sigma-1 receptor is extensively expressed within the central nervous system and is acknowledged to play a key function in calcium homeostasis. Remedies with agonists of the sigma-1 receptor induce useful results in a number of animal fashions of neurological ailments. In traumatic harm the usage of an antagonist of the sigma-1 receptor reversed a number of signs of central neuropathic ache.
Right here, we investigated whether or not sigma-1 receptor activation with PRE-084 is useful or detrimental following SCI in mice. First, we report that PRE-084 therapy after harm doesn’t enhance motor operate restoration. Second, utilizing ex vivo diffusion weighted magnetic resonance imaging accomplished by histological evaluation, we spotlight that σ1R agonist therapy after SCI doesn’t restrict lesion measurement.
Lastly, PRE-084 therapy following SCI decreases NeuN expression and will increase astrocytic reactivity. Our findings recommend that activation of sigma-1 receptor after traumatic spinal wire harm is detrimental on tissue preservation and motor operate restoration in mice.
Protecting Impact of Adenosine A 2B Receptor Agonist, BAY60-6583, In opposition to Transient Focal Mind Ischemia in Rat
Cerebral ischemia is a multifactorial pathology characterised first by an acute harm, attributable to excitotoxicity, adopted by a secondary mind harm that develops hours to days after ischemia. Throughout ischemia, adenosine acts as an endogenous neuroprotectant. Few research have investigated the function of A2B receptor in mind ischemia due to the low efficiency of adenosine for it and the few selective ligands developed up to now.
A2B receptors are scarcely however extensively distributed within the mind on neurons, glial and endothelial cells and on hematopoietic cells, lymphocytes and neutrophils, the place they exert primarily anti-inflammatory results, inhibiting vascular adhesion and inflammatory cells migration. Intention of this work was to confirm whether or not continual administration of the A2B agonist, BAY60-6583 (0.1 mg/kg i.p., twice/day), beginning Four h after focal ischemia induced by transient (1 h) Center Cerebral Artery occlusion (tMCAo) within the rat, was protecting after the ischemic insult.
BAY60-6583 improved the neurological deficit as much as 7 days after tMCAo. Seven days after ischemia BAY60-6583 diminished considerably the ischemic mind harm in cortex and striatum, counteracted ischemia-induced neuronal demise, diminished microglia activation and astrocytes alteration. Furthermore, it decreased the expression of TNF-α and elevated that of IL-10 in peripheral plasma.
ẞ-Agonists ELISA Kit |
ELKFS047 |
ELK Biotech |
96Tests |
EUR 175 |
beta-agonist (β-agonist) ELISA Kit |
RDF-E078 |
Reddot Biotech |
96T |
EUR 480 |
|
THR-β agonist 5 |
HY-147055 |
MedChemExpress |
1 mg |
EUR 1623.4 |
Description: THR-β agonist 5 (compound 54) is a potent THR-β agonist, with an EC50 of <50 nM[1]. |
THR-β agonist 6 |
HY-149218 |
MedChemExpress |
Get quote |
Ask for price |
Description: THR-β agonist 6 is an orally active, selective thyroid hormone receptor β (THR-β) agonist with EC50s of 0.03 μM and 0.22 μM for THR-β and THR-α, respectively. THR-β agonist 6 exhibits an xcellent liver-to-serum ratio of 93:1 in mice. THR-β agonist 6 has the potential for nonalcoholic steatohepatitis (NASH) research[1]. |
THR-β agonist 7 |
HY-160266 |
MedChemExpress |
Get quote |
Ask for price |
Description: THR-β agonist-1 (Example 2) is a THR-β agonist, with EC50 values of 52 nM and 1017 nM for THR-β and THR-α, respectively[1]. |
THR-β agonist 1 |
HY-142441 |
MedChemExpress |
Get quote |
Ask for price |
Description: THR-β Agonist 1 is a potent and selective agonist of THRβ. Thyroid hormone receptor mediates the physiological activity of thyroid hormones which plays a key role in normal growth and development of the body and in maintaining metabolic balance. THR-β Agonist 1 has the potential for the research of thyroid hormone receptor-related diseases (extracted from patent WO2021104288A1, compound 2)[1]. |
THR-β agonist 4 |
HY-142917 |
MedChemExpress |
Get quote |
Ask for price |
Description: THR-β agonist 4 is a potent agonist of THR-β. THR-β agonist 4 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021143706A1, compound 72)[1]. |
THR-β agonist 2 |
HY-143613 |
MedChemExpress |
Get quote |
Ask for price |
Description: THR-β agonist 2 is a potent agonist of THR-β. THR-β agonist 2 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021121210A1, compound 3)[1]. |
THR-β agonist 3 |
HY-143614 |
MedChemExpress |
Get quote |
Ask for price |
Description: THR-β agonist 3 is a potent agonist of THR-β. THR-β agonist 3 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021129827A1, compound 6)[1]. |
THR-β agonist 5 |
T61759-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: THR-β agonist 5 |
THR-β agonist 5 |
T61759-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: THR-β agonist 5 |
THR-β agonist 4 |
T63515-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: THR-β agonist 4 |
THR-β agonist 4 |
T63515-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: THR-β agonist 4 |
THR-β agonist 3 |
T63697-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: THR-β agonist 3 |
THR-β agonist 3 |
T63697-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: THR-β agonist 3 |
THR-β agonist 1 |
T62570-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: THR-β agonist 1 |
THR-β agonist 1 |
T62570-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: THR-β agonist 1 |
THR-β agonist 2 |
T62594-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: THR-β agonist 2 |
THR-β agonist 2 |
T62594-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: THR-β agonist 2 |
Wnt/β-catenin agonist 1 |
HY-114321 |
MedChemExpress |
10 mg |
EUR 2543.33 |
Description: Wnt/β-catenin agonist 1 (compound 3f) is a Wnt/β-catenin signalling pathway agonist, with an EC50 of 0.27 μM[1]. |
Wnt/β-catenin agonist 3 |
HY-148055 |
MedChemExpress |
10 mg |
EUR 487.02 |
Description: Wnt/β-catenin agonist 3 (compound 98) is a Wnt/β-catenin signalling pathway agonist. Wnt/β-catenin agonist 3 can be used for the research of osteoporosis[1]. |
Wnt/β-catenin agonist 4 |
HY-151520 |
MedChemExpress |
10 mg |
EUR 432.91 |
Description: Wnt/β-catenin agonist 4 (Derivative 83) is an agonist of Wnt that activates Wnt/β-catenin signal transmission[1]. |
Wnt/β-catenin agonist 2 |
HY-141873 |
MedChemExpress |
10 mg |
EUR 1461.06 |
Description: Wnt/β-catenin agonist 2 is a potent Wnt agonist. Wnt/β-catenin agonist 2 activates Wnt/β-catenin signaling and can be used in the research of diseases related to the signal transduction[1]. (From patent WO2007078113A1, compound 39) |
Wnt/β-catenin agonist 1 |
T13344-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: Wnt/β-catenin agonist 1 |
Wnt/β-catenin agonist 1 |
T13344-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: Wnt/β-catenin agonist 1 |
Wnt/β-catenin agonist 1 |
T13344-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: Wnt/β-catenin agonist 1 |
Wnt/β-catenin agonist 1 |
T13344-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: Wnt/β-catenin agonist 1 |
Wnt/β-catenin agonist 1 |
T13344-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: Wnt/β-catenin agonist 1 |
Wnt/β-catenin agonist 4 |
T60803-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: Wnt/β-catenin agonist 4 |
Wnt/β-catenin agonist 4 |
T60803-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: Wnt/β-catenin agonist 4 |
Wnt/β-catenin agonist 4 |
T60803-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: Wnt/β-catenin agonist 4 |
Wnt/β-catenin agonist 4 |
T60803-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: Wnt/β-catenin agonist 4 |
Wnt/β-catenin agonist 4 |
T60803-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: Wnt/β-catenin agonist 4 |
Wnt/β-catenin agonist 2 |
T41094-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: Wnt/β-catenin agonist 2 |
Wnt/β-catenin agonist 2 |
T41094-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: Wnt/β-catenin agonist 2 |
Wnt/β-catenin agonist 2 |
T41094-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: Wnt/β-catenin agonist 2 |
Wnt/β-catenin agonist 2 |
T41094-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: Wnt/β-catenin agonist 2 |
Wnt/β-catenin agonist 2 |
T41094-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: Wnt/β-catenin agonist 2 |
Wnt/β-catenin agonist 3 (hydrochloride) |
HY-148055A |
MedChemExpress |
10 mg |
EUR 91.99 |
Description: Wnt/β-catenin agonist 3 hydrochloride is a Wnt/β-catenin signalling pathway agonist. Wnt/β-catenin agonist 3 (compound 98) can be used for the research of osteoporosis[1]. |
Bid ELISA Kit| Mouse BH3 Interacting Domain Death Agonist ELISA |
EF013466 |
Lifescience Market |
96 Tests |
EUR 826.8 |
Rat BH3 Interacting Domain Death Agonist ELISA Kit |
MBS721688-48StripWellsCompetitive |
MyBiosource |
48-Strip-Wells-(Competitive) |
EUR 485 |
Rat BH3 Interacting Domain Death Agonist ELISA Kit |
MBS721688-48StripWellsSandwich |
MyBiosource |
48-Strip-Wells-(Sandwich) |
EUR 485 |
Rat BH3 Interacting Domain Death Agonist ELISA Kit |
MBS721688-5x96StripWellsCompetitive |
MyBiosource |
5x96-Strip-Wells-(Competitive) |
EUR 3020 |
Rat BH3 Interacting Domain Death Agonist ELISA Kit |
MBS721688-96StripWellsCompetitive |
MyBiosource |
96-Strip-Wells-(Competitive) |
EUR 690 |
Rat BH3 Interacting Domain Death Agonist ELISA Kit |
MBS721688-96StripWellsSandwich |
MyBiosource |
96-Strip-Wells-(Sandwich) |
EUR 690 |
Rat BH3 Interacting Domain Death Agonist ELISA kit |
E01A10462 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Rat BH3 Interacting Domain Death Agonist ELISA kit |
E02B0306-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rat BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat BH3 Interacting Domain Death Agonist ELISA kit |
E02B0306-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rat BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat BH3 Interacting Domain Death Agonist ELISA kit |
E02B0306-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rat BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog BH3 Interacting Domain Death Agonist ELISA kit |
E08B0306-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Canine BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog BH3 Interacting Domain Death Agonist ELISA kit |
E08B0306-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Canine BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog BH3 Interacting Domain Death Agonist ELISA kit |
E08B0306-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Canine BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig BH3 Interacting Domain Death Agonist ELISA kit |
E07B0306-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Porcine BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig BH3 Interacting Domain Death Agonist ELISA kit |
E07B0306-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Porcine BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig BH3 Interacting Domain Death Agonist ELISA kit |
E07B0306-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Porcine BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Cat Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS084205-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Rat Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS045681-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Rat Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS045681-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Rat Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS045681-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Rat Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS045681-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Rat BH3 Interacting Domain Death Agonist ELISA Kit |
IRTBIDKT |
Innovative research |
each |
EUR 718 |
|
Description: Rat BH3 Interacting Domain Death Agonist ELISA Kit |
Goat BH3 Interacting Domain Death Agonist ELISA kit |
E01A45374 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Goat BH3 Interacting Domain Death Agonist ELISA kit |
E06B0306-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Goat BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat BH3 Interacting Domain Death Agonist ELISA kit |
E06B0306-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Goat BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat BH3 Interacting Domain Death Agonist ELISA kit |
E06B0306-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Goat BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Duck Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS087967-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Goat Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS045425-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Fish Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS045624-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Cavy Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS036082-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Goat BH3 Interacting Domain Death Agonist ELISA Kit |
MBS737715-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 5685 |
Goat BH3 Interacting Domain Death Agonist ELISA Kit |
MBS737715-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 485 |
Goat BH3 Interacting Domain Death Agonist ELISA Kit |
MBS737715-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3020 |
Goat BH3 Interacting Domain Death Agonist ELISA Kit |
MBS737715-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 690 |
Bid ELISA Kit| Rat BH3-interacting domain death agonist ELISA Ki |
EF017208 |
Lifescience Market |
96 Tests |
EUR 826.8 |
Human BH3 Interacting Domain Death Agonist ELISA Kit |
MBS721310-48StripWellsCompetitive |
MyBiosource |
48-Strip-Wells-(Competitive) |
EUR 485 |
Human BH3 Interacting Domain Death Agonist ELISA Kit |
MBS721310-48StripWellsSandwich |
MyBiosource |
48-Strip-Wells-(Sandwich) |
EUR 485 |
Human BH3 Interacting Domain Death Agonist ELISA Kit |
MBS721310-5x96StripWellsCompetitive |
MyBiosource |
5x96-Strip-Wells-(Competitive) |
EUR 3020 |
Human BH3 Interacting Domain Death Agonist ELISA Kit |
MBS721310-96StripWellsCompetitive |
MyBiosource |
96-Strip-Wells-(Competitive) |
EUR 690 |
Human BH3 Interacting Domain Death Agonist ELISA Kit |
MBS721310-96StripWellsSandwich |
MyBiosource |
96-Strip-Wells-(Sandwich) |
EUR 690 |
Mouse BH3 Interacting Domain Death Agonist ELISA Kit |
MBS721937-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 5685 |
Mouse BH3 Interacting Domain Death Agonist ELISA Kit |
MBS721937-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 485 |
Mouse BH3 Interacting Domain Death Agonist ELISA Kit |
MBS721937-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3020 |
Mouse BH3 Interacting Domain Death Agonist ELISA Kit |
MBS721937-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 690 |
BH3-Interacting Domain Death Agonist (BID) ELISA Kit |
abx595062-96tests |
Abbexa |
96 tests |
EUR 764.4 |
|
Human BH3 Interacting Domain Death Agonist ELISA kit |
E01A1700 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Mouse BH3 Interacting Domain Death Agonist ELISA kit |
E01A19203 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Mouse BH3 Interacting Domain Death Agonist ELISA kit |
E03B0306-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Mouse BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse BH3 Interacting Domain Death Agonist ELISA kit |
E03B0306-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Mouse BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse BH3 Interacting Domain Death Agonist ELISA kit |
E03B0306-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Mouse BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Sheep BH3 Interacting Domain Death Agonist ELISA kit |
E01A97667 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Human BH3 Interacting Domain Death Agonist ELISA kit |
E01B0306-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Human BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human BH3 Interacting Domain Death Agonist ELISA kit |
E01B0306-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Human BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human BH3 Interacting Domain Death Agonist ELISA kit |
E01B0306-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Human BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Camel Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS089066-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Camel Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS089066-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Camel Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS089066-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Camel Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS089066-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Horse Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS009491-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Horse Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS009491-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Horse Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS009491-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Horse Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS009491-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Sheep Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS012456-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Sheep Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS012456-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Sheep Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS012456-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Sheep Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS012456-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Mouse Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS024701-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Mouse Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS024701-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Mouse Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS024701-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Mouse Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS024701-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Goose Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS014736-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Human Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS023113-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS023113-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Human Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS023113-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Human Bh3 Interacting Domain Death Agonist ELISA Kit |
MBS023113-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Mouse BH3 Interacting Domain Death Agonist ELISA Kit |
IMSBIDKT |
Innovative research |
each |
EUR 616 |
|
Description: Mouse BH3 Interacting Domain Death Agonist ELISA Kit |
Human BH3 Interacting Domain Death Agonist ELISA Kit |
IHUBIDKT |
Innovative research |
each |
EUR 667 |
|
Description: Human BH3 Interacting Domain Death Agonist ELISA Kit |
Rat BH3-interacting domain death agonist ELISA Kit |
MBS289579-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 4080 |
Rat BH3-interacting domain death agonist ELISA Kit |
MBS289579-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 390 |
Rat BH3-interacting domain death agonist ELISA Kit |
MBS289579-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 2220 |
Rat BH3-interacting domain death agonist ELISA Kit |
MBS289579-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 520 |
Pig BH3-interacting domain death agonist ELISA Kit |
MBS2886061-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 4630 |
Pig BH3-interacting domain death agonist ELISA Kit |
MBS2886061-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 440 |
Pig BH3-interacting domain death agonist ELISA Kit |
MBS2886061-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 2480 |
Pig BH3-interacting domain death agonist ELISA Kit |
MBS2886061-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 580 |
Sheep BH3 Interacting Domain Death Agonist ELISA Kit |
MBS738222-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 5685 |
Sheep BH3 Interacting Domain Death Agonist ELISA Kit |
MBS738222-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 485 |
Sheep BH3 Interacting Domain Death Agonist ELISA Kit |
MBS738222-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3020 |
Sheep BH3 Interacting Domain Death Agonist ELISA Kit |
MBS738222-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 690 |
Rat BH3-interacting domain death agonist ELISA Kit |
MBS762685-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3900 |
Rat BH3-interacting domain death agonist ELISA Kit |
MBS762685-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 340 |
Rat BH3-interacting domain death agonist ELISA Kit |
MBS762685-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 2045 |
Rat BH3-interacting domain death agonist ELISA Kit |
MBS762685-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 455 |
Rat BH3-interacting domain death agonist ELISA Kit |
MBS9425901-5x96Tests |
MyBiosource |
5x96Tests |
EUR 2820 |
Rat BH3-interacting domain death agonist ELISA Kit |
MBS9425901-96Tests |
MyBiosource |
96Tests |
EUR 615 |
Mouse BH3 Interacting Domain Death Agonist ELISA Kit |
MBS765103-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3900 |
Mouse BH3 Interacting Domain Death Agonist ELISA Kit |
MBS765103-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 340 |
Mouse BH3 Interacting Domain Death Agonist ELISA Kit |
MBS765103-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 2045 |
Mouse BH3 Interacting Domain Death Agonist ELISA Kit |
MBS765103-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 455 |
Rat BH3 interacting domain death agonist,Bid ELISA Kit |
CN-01707R1 |
ChemNorm |
96T |
EUR 556.8 |
Rat BH3 interacting domain death agonist,Bid ELISA Kit |
CN-01707R2 |
ChemNorm |
48T |
EUR 375.6 |
Pig BH3 Interacting Domain Death Agonist (BID) ELISA Kit |
abx360959-100g |
Abbexa |
100 µg |
EUR 687.5 |
Pig BH3 Interacting Domain Death Agonist (BID) ELISA Kit |
abx360959-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Rat BH3 Interacting Domain Death Agonist (Bid) ELISA Kit |
abx155258-100l |
Abbexa |
100 µl |
EUR 675 |
Rat BH3 Interacting Domain Death Agonist (Bid) ELISA Kit |
20-abx155258 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
- 96 tests
- 5 × 96 tests
- 10 × 96 tests
|
|
Rat BH3 Interacting Domain Death Agonist (BID) ELISA Kit |
abx256314-1096tests |
Abbexa |
10 × 96 tests |
Ask for price |
Rat BH3 Interacting Domain Death Agonist (BID) ELISA Kit |
abx256314-596tests |
Abbexa |
5 × 96 tests |
Ask for price |
Rat BH3 Interacting Domain Death Agonist (BID) ELISA Kit |
abx256314-96tests |
Abbexa |
96 tests |
EUR 531.25 |
|
Rat BH3 Interacting Domain Death Agonist (BID) ELISA Kit |
abx572028-96tests |
Abbexa |
96 tests |
EUR 848.4 |
|
Two days after ischemia BAY60-6583 diminished blood cell infiltration within the ischemic cortex. The current examine signifies that A2B receptors stimulation can attenuate the neuroinflammation that develops after ischemia, suggesting that A2B receptors could characterize a brand new attention-grabbing pharmacological goal to guard from degeneration after mind ischemia.
Tags :
medium serum free,
nattrol controls,
nattrol ct/ng panel,
nattrol influenza a/b positive control sds,
nattrol respiratory verification panel,
nattrol strep a,
nattrol vaginal panel zeptometrix,
panel app,
panel beater,
panel beds,
panel champ,
panel control,
panel de control,
panel de pon,
panel door,
panel quilts ideas,
panel siding,
panel tactil,
panel truck,
panel van,
panela,
panela cheese,
paneles solares,
paneling,
paneling for walls,
panelist,
panella,
panelling,
panelpolls,
panels4less,
paneltronics,
particles and atoms,
peptides t3,
peptides tadalafil,
peptides vs hgh,
peptides warehouse,
peptides warehouse scam,
peptidescience.com,
peptidesciences,
reagents coa,
reagents define,
reagents defined,
reagents definition,
reagents eso,
reagents for corona testing,
reagents for organic synthesis,
reagents nc,
reagents needed for covid-19 test,
reagents qc,
reagents s.a,
reagents sds,
reagents that break double bonds,
reagents undercity,
reagents used for pcr,
reagents usp,
reagents vendor,
reagents vendor orgrimmar,
reagents vendor tb,
reagents vendor uc,
recombinant proteins,
recombinant proteins biotechnology,
recombinant proteins definition,
recombinant proteins examples,
recombinant proteins ppt,
recombinant proteins production,
recombinant proteins sds page gel,
recombinant proteins technology